Evotec earns milestone payment as FDA clears IND for CELMoD candidate
12th November 2025 Uncategorised 0
US$5m payment from Bristol Myers Squibb marks progress in protein degradation partnership

More: Evotec earns milestone payment as FDA clears IND for CELMoD candidate
Source: News
